- Home
- CLDX vs GBX Comparison
CLDX vs GBX Comparison
Compare CLDX & GBX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CLDX
- GBX
- Stock Information
- Founded
- CLDX N/A
- GBX 1974
- Country
- CLDX United States
- GBX United States
- Employees
- CLDX N/A
- GBX N/A
- Industry
- CLDX Biotechnology: In Vitro & In Vivo Diagnostic Substances
- GBX Railroads
- Sector
- CLDX Health Care
- GBX Industrials
- Exchange
- CLDX Nasdaq
- GBX Nasdaq
- Market Cap
- CLDX 1.3B
- GBX 1.4B
- IPO Year
- CLDX 2008
- GBX N/A
- Fundamental
- Price
- CLDX $23.36
- GBX $52.21
- Analyst Decision
- CLDX Buy
- GBX Hold
- Analyst Count
- CLDX 9
- GBX 2
- Target Price
- CLDX $50.00
- GBX $59.50
- AVG Volume (30 Days)
- CLDX 1.1M
- GBX 545.0K
- Earning Date
- CLDX 08-07-2025
- GBX 07-01-2025
- Dividend Yield
- CLDX N/A
- GBX 2.43%
- EPS Growth
- CLDX N/A
- GBX 88.14
- EPS
- CLDX N/A
- GBX 7.10
- Revenue
- CLDX $7,559,000.00
- GBX $3,533,700,000.00
- Revenue This Year
- CLDX N/A
- GBX N/A
- Revenue Next Year
- CLDX N/A
- GBX N/A
- P/E Ratio
- CLDX N/A
- GBX $7.43
- Revenue Growth
- CLDX 24.49
- GBX 0.70
- 52 Week Low
- CLDX $14.40
- GBX $37.77
- 52 Week High
- CLDX $47.00
- GBX $71.06
- Technical
- Relative Strength Index (RSI)
- CLDX 64.61
- GBX 62.72
- Support Level
- CLDX $20.76
- GBX $54.34
- Resistance Level
- CLDX $23.55
- GBX $57.48
- Average True Range (ATR)
- CLDX 1.22
- GBX 1.55
- MACD
- CLDX 0.20
- GBX 0.46
- Stochastic Oscillator
- CLDX 95.29
- GBX 65.62
About CLDX Celldex Therapeutics Inc.
Celldex Therapeutics Inc is a biopharmaceutical company. It is focused on the development and commercialization of several immunotherapy technologies and other cancer-targeting biologics. The company is also engaged in clinical trials for products targeting breast cancer, metastatic melanoma, lung cancer, solid tumors, and ovarian cancer. It has single operating and reportable segment that operates in the business of development, manufacturing and commercialization of novel therapeutics for human health care.
About GBX Greenbrier Companies Inc. (The)
Greenbrier Companies Inc designs, manufactures, and markets railroad freight car equipment in North America and Europe, marine barges in North America and provides wheel services, railcar refurbishment, and parts, leasing and other services to the railroad. Its segments include Manufacturing, Maintenance Services and Leasing & Management Services. The company generates a majority of its revenue from the manufacturing segment. Geographically, it derives a majority of its revenue from the United States.